Sunshine Biopharma (SBFM)

• Market cap: $5.17M
• 1 day: -9.48%
• 5 days: -17.32%
• 1 month: -23.29%
• 3 months: -30.55%
• 6 months: -31.79%
• Year to date: -38.98%
• 1 year: -98.12%
• 5 years: -99.96%
• 10 years: -99.96%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Employees: 44

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

20% more funds holding

Funds holding: 10 [Q3] → 12 (+2) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

1.84% less ownership

Funds ownership: 2.87% [Q3] → 1.03% (-1.84%) [Q4]

45% less capital invested

Capital invested by funds: $111K [Q3] → $61.7K (-$49.5K) [Q4]